HIVE director receives 12,500 shares from RSUs
A HIVE Digital Technologies director reported RSU vesting into 12,500 common shares and disclosed 312,500 RSUs remaining with scheduled vesting through 2027.
Rhea-AI Filing Summary
HIVE Digital Technologies Ltd. (HIVE) director Susan B. McGee reported the vesting and settlement of 12,500 Restricted Share Units (RSUs) on September 4, 2026. These RSUs, awarded on November 5, 2024, converted on a one-for-one basis into 12,500 common shares, bringing her directly held common shares to 112,500 and her remaining RSUs to 312,500.
The remaining RSUs are scheduled to vest in tranches of 100,000 on October 31, 2026, 12,500 on November 5, 2026, 100,000 on March 16, 2027, and 100,000 on June 30, 2027. No Rule 10b5-1 trading plan is reported for these transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Share Units F1, F2, F3 | 12,500 | $0.00 | $0.00 |
| Exercise | Common Shares F1, F2 | 12,500 | -- | -- |
Footnotes (3)
- F1. Reflects restricted share units ("RSUs") issued pursuant to the Issuerâs Restricted Share Unit Plan (the "RSU Plan") that, upon vesting and settlement converted into shares of the Issuerâs common stock on a one-for-one basis.
- F2. Reflects 12,500 RSUs that were awarded on November 5, 2024 and vested on August 5, 2026. These RSUs were settled and converted into common shares of the Issuer on September 4, 2026, in accordance with the Issuer's RSU Plan.
- F3. The RSUs reported under Column 9 include RSUs that were previously reported. The underlying shares and vesting schedules are as follows: (i) 100,000 will vest on October 31, 2026; (ii) 12,500 will vest on November 5, 2026; (iii) 100,000 will vest on March 16, 2027 and (iv) 100,000 will vest on June 30, 2027.
Key Figures
Key Terms
RSU Plan financial
vested financial
one-for-one basis financial
FAQ
What insider transaction did HIVE director Susan B. McGee report on this Form 4?
How many RSUs in HIVE does the director still hold after this Form 4 event?
What is the vesting schedule for the remaining RSUs reported by HIVE’s director?
Was a Rule 10b5-1 trading plan involved in the HIVE director’s Form 4 transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.